We are live on
!
Find out more
Adage Capital Partners Portfolio holdings
AUM
$64.8B
1-Year Est. Return
42.7%
This Fund
S&P 500
This Quarter
Est. Return
-13.87%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+829.83%
AUM
$36.1B
AUM Growth
-$8.74B
(-19%)
Cap. Flow
-$2.16B
Cap. Flow
% of AUM
-6%
Top 10 Holdings %
Top 10 Hldgs %
15.58%
Holding
799
New
91
Increased
212
Reduced
361
Closed
95
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GE Aerospace
GE
|
+$347M |
| 2 |
Wayfair
W
|
+$199M |
| 3 |
RTX Corp
RTX
|
+$140M |
| 4 |
Sarepta Therapeutics
SRPT
|
+$131M |
| 5 |
CVS Health
CVS
|
+$121M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AET
Aetna Inc
AET
|
+$946M |
| 2 |
SHPG
Shire pic
SHPG
|
+$472M |
| 3 |
Deere & Co
DE
|
+$326M |
| 4 |
COL
Rockwell Collins
COL
|
+$286M |
| 5 |
ANDV
Andeavor
ANDV
|
+$221M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.2% |
| 2 | Technology | 13.74% |
| 3 | Financials | 12.51% |
| 4 | Industrials | 12.28% |
| 5 | Consumer Discretionary | 11.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
351
NetApp
NTAP
$35B
| $18.7M | 0.05% |
313,600
-26,300
| -8% | -$1.89M |
|
352
Hershey
HSY
$35.2B
| $18.6M | 0.05% |
173,785
-2,500
| -1% | -$266K |
|
353
American Express
AXP
$227B
| $18.6M | 0.05% |
195,050
-599,000
| -75% | -$62.7M |
|
354
Abeona Therapeutics
ABEO
$366M
| $18.6M | 0.05% |
104,000
+25,000
| +32% | +$5.45M |
|
|
BHVN
355
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $18.5M | 0.05% |
+500,000
| New | +$18M |
|
356
American Airlines Group
AAL
$10.1B
| $18.3M | 0.05% |
570,392
-2,906,022
| -84% | -$101M |
|
|
ABMD
357
DELISTED
Abiomed Inc
ABMD
| $18.2M | 0.05% |
56,016
+21,416
| +62% | +$7.44M |
|
|
OPTU
358
Optimum Communications Inc
OPTU
$298M
| $18.2M | 0.05% |
+1,100,000
| New | +$19.1M |
|
|
VAPO
359
DELISTED
Vapotherm, Inc. Common Stock
VAPO
| $18.1M | 0.05% |
+113,565
| New | +$16.4M |
|
|
RDS.A
360
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $18.1M | 0.05% |
310,274
-175,000
| -36% | -$10.9M |
|
|
EIGR
361
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $18M | 0.05% |
59,167
+36,427
| +160% | +$11.8M |
|
362
VF Corp
VFC
$5.63B
| $18M | 0.05% |
268,350
-59,720
| -18% | -$4.57M |
|
|
K
363
DELISTED
Kellanova
K
| $17.9M | 0.05% |
335,088
+8,374
| +3% | +$506K |
|
364
Advanced Micro Devices
AMD
$776B
| $17.9M | 0.05% |
971,323
+60,000
| +7% | +$1.3M |
|
|
AMCIU
365
DELISTED
AMCI Acquisition Corp Unit
AMCIU
| $17.9M | 0.05% |
+1,800,000
| New | +$18M |
|
366
Lumen
LUMN
$6.57B
| $17.8M | 0.05% |
1,177,809
-57,700
| -5% | -$1.1M |
|
|
VNTR
367
DELISTED
Venator Materials PLC
VNTR
| $17.7M | 0.05% |
+4,232,394
| New | +$27.3M |
|
368
Cintas
CTAS
$81.9B
| $17.6M | 0.05% |
419,600
-21,200
| -5% | -$948K |
|
369
Raymond James Financial
RJF
$33.8B
| $17.6M | 0.05% |
353,850
+100,800
| +40% | +$5.37M |
|
|
SEI
370
Solaris Energy Infrastructure
SEI
$3.15B
| $17.4M | 0.05% |
1,435,367
+480,808
| +50% | +$6.83M |
|
371
Novartis
NVS
$297B
| $17.2M | 0.05% |
+223,200
| New | +$17.4M |
|
372
Arrowhead Research
ARWR
$11.9B
| $17.1M | 0.05% |
1,375,000
+475,000
| +53% | +$6.49M |
|
|
CPE
373
DELISTED
Callon Petroleum Company
CPE
| $17.1M | 0.05% |
263,136
-30,000
| -10% | -$2.9M |
|
374
Masco
MAS
$14.1B
| $17.1M | 0.05% |
583,300
-852,918
| -59% | -$26.5M |
|
|
CBAY
375
DELISTED
Cymabay Therapeutics
CBAY
| $17M | 0.05% |
2,160,150
+185,150
| +9% | +$1.76M |
|
Similar funds
Adage Capital Partners's Q4 2018 Portfolio in Review
As of Q4 2018, Adage Capital Partners held 799 positions worth $36.1B, down 19% from $44.8B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Adage Capital Partners withdrew a net $2.16B in Q4 2018, closing 95 positions and reducing 361 holdings. Its most notable exit was Aetna Inc, an estimated $946M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 15% a quarter earlier, followed by Technology and Financials.
Against the trend, Adage Capital Partners opened a new position in CVS Health worth $106M.
- Adage Capital Partners's largest Q4 2018 buy was CVS Health: 1,619,774 shares worth $106M.
- Adage Capital Partners added most to GE Aerospace in Q4 2018, an estimated $347M increase.
- Adage Capital Partners's biggest Q4 2018 reduction was Shire pic, cutting an estimated $472M.
- Adage Capital Partners fully exited Aetna Inc in Q4 2018, selling an estimated $946M.
- Adage Capital Partners's ten largest holdings make up 16% of its $36.1B portfolio in Q4 2018.
- Adage Capital Partners opened 91 new positions and closed 95 in Q4 2018.
- Adage Capital Partners's portfolio value fell 19% quarter-over-quarter to $36.1B.
Based on Adage Capital Partners's 13F filing for Q4 2018, filed 14 Feb 2019.